Godavari Biorefineries Ltd

Godavari Biorefineries will hold a meeting of the Board of Directors of the Company on 5 August 2026.

The company currently operates a 600 KLPD distillery based on sugarcane juice and syrup. The newly commissioned capacity of 200 KLPD has been set up at an estimated cost of Rs 130 crore, financed through internal accruals and debt. According to the company, the addition of the grain-based distillery provides dual-feedstock capability, enabling more resilient ethanol production by reducing dependence on sugarcane and ensuring operational continuity during climate-related disruptions. Godavari Biorefineries is a leading integrated biorefinery focused on the production of bio-based chemicals, ethanol, sugar, and power. The company is among the larger ethanol producers in India and is a pioneer in manufacturing ethanol-based chemicals. It operates advanced manufacturing facilities at Sakarwadi in Maharashtra and Sameerwadi in Karnataka, along with three research and development centres located in Mumbai and its plant locations. On the financial front, the company reported a 26.48% decline in consolidated net profit to Rs 52.88 crore for the quarter ended March 2026, compared with Rs 71.93 crore in the corresponding quarter of the previous year. Consolidated sales declined 2.66% to Rs 564.10 crore during the quarter from Rs 579.50 crore recorded in the same period last year.Powered by Capital Market - Live

Godavari Biorefineries announced that the Japanese Patent Office has granted its patent, 5-HYDROXY 1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER,. This patent covers a novel class of compounds that exhibit strong inhibitory effects on cancer and cancer stem cells, demonstrating significant efficacy against multiple types, including breast and prostate cancer.

According to the company, the patent covers a novel class of compounds that have demonstrated strong inhibitory effects on cancer cells and cancer stem cells. The compounds have shown significant efficacy against multiple cancer types, including breast and prostate cancer, highlighting their potential therapeutic applications. Godavari Biorefineries is a leading integrated biorefinery focused on the production of bio-based chemicals, ethanol, sugar, and power. The company is among the larger ethanol producers in India and is a pioneer in manufacturing ethanol-based chemicals. It operates advanced manufacturing facilities at Sakarwadi in Maharashtra and Sameerwadi in Karnataka, along with three research and development centres located in Mumbai and its plant locations. On the financial front, the company reported a 26.48% decline in consolidated net profit to Rs 52.88 crore for the quarter ended March 2026, compared with Rs 71.93 crore in the corresponding quarter of the previous year. Consolidated sales declined 2.66% to Rs 564.10 crore during the quarter from Rs 579.50 crore recorded in the same period last year. Powered by Capital Market - Live

Net profit of Godavari Biorefineries declined 26.48% to Rs 52.88 crore in the quarter ended March 2026 as against Rs 71.93 crore during the previous quarter ended March 2025. Sales declined 2.66% to Rs 564.10 crore in the quarter ended March 2026 as against Rs 579.50 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 3.53 crore in the year ended March 2026 as against net loss of Rs 23.41 crore during the previous year ended March 2025. Sales rose 6.29% to Rs 1987.94 crore in the year ended March 2026 as against Rs 1870.25 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales564.10579.50 -3 1987.941870.25 6 OPM %15.2819.40 -6.395.54 - PBDT80.81108.58 -26 90.2048.52 86 PBT66.8995.74 -30 35.71-1.54 LP NP52.8871.93 -26 3.53-23.41 LP Powered by Capital Market - Live

Godavari Biorefineries will hold a meeting of the Board of Directors of the Company on 22 May 2026.

The agency has also affirmed the company's short-term rating at 'CARE A2'. Care Ratings stated that the reaffirmation of ratings assigned to bank facilities of Godavari Biorefineries (GBL) reflects the company's adequate operating performance in FY25 and 9M FY26, despite industry-wide headwinds of reduced profitability owing to higher sugarcane prices, restrictions on sugar exports and limited availability of molasses following the restriction on diversion of sugar syrup for ethanol production. CARE Ratings expects the company's performance to sustain over the medium term, driven by its sizeable crushing and distillery capacities and long track record of operations. Ratings continue to derive comfort from GBL's integrated sugar unit, proximity to high-yielding sugarcane cultivating regions and diversified product portfolio comprising sugar, distillery, co-generation and bio-based chemicals, which mitigates concentration risk. GBL's business risk profile also benefits from the company's strong and resourceful promoters, Somaiya Group, with a long track record in agri-based businesses and education sector. However, ratings continue to remain constrained by the company's moderate capital structure and debt coverage indicators, despite some improvement in FY25 led by sizeable increase in net worth base and prepayment of term loans following the fresh equity infusion through the initial public offering (IPO) in Q3FY25, owing to continued debt-funded capital expenditure for setting up the fungible grain-based distillery and working capital intensive operations. Ratings also factor in GBL's presence in a highly regulated industry and its exposure to agri-climatic risks and cyclical nature of sugar industry. Godavari Biorefineries has two units, one is an integrated plant producing sugar, power and industrial alcohol, and second unit produces bio-based specialty chemicals. The company's chemicals division exports ethyl acetate to the Middle East, Africa, and European countries. The company has an in-house retail brand 'Jivana' for the sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat. The company's consolidated net profit increased by 43.23% to Rs 8.25 crore on a 2.81% rise in revenue to Rs 459.85 crore in Q3 FY26 as compared with Q3 FY25. The scrip jumped 5.22% to end at Rs 324.35 on the BSE. Powered by Capital Market - Live

Net profit of Godavari Biorefineries rose 43.23% to Rs 8.25 crore in the quarter ended December 2025 as against Rs 5.76 crore during the previous quarter ended December 2024. Sales rose 2.81% to Rs 459.85 crore in the quarter ended December 2025 as against Rs 447.27 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales459.85447.27 3 OPM %9.378.07 - PBDT34.9220.81 68 PBT21.378.47 152 NP8.255.76 43 Powered by Capital Market - Live

Godavari Biorefineries will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live

Net Loss of Godavari Biorefineries reported to Rs 41.59 crore in the quarter ended September 2025 as against net loss of Rs 75.00 crore during the previous quarter ended September 2024. Sales rose 34.21% to Rs 430.75 crore in the quarter ended September 2025 as against Rs 320.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales430.75320.95 34 OPM %-1.84-10.16 - PBDT-16.72-51.81 68 PBT-30.24-64.11 53 NP-41.59-75.00 45 Powered by Capital Market - Live